Novartis Halts Hepatitis Drug Trial After Death

In CategoryDeath and Dying, Drugs and Drug Companies
ByRuss Bianchi

Swiss pharmaceutical company Novartis AG says it has halted clinical trials for a new drug to treat hepatitis after one patient died.

Novartis Halts Hepatitis Drug Trial After Death

Share

Tags: , ,

Comments are closed.